Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.

The merger will create a specialty company, REGiMMUNE/Kiji TX, for regulatory T cells.

Meanwhile, Kiji, which is based in France and Spain, has been working on a next-gen multigene engineered stem cell therapy IL10 enhancer ... inhibiting monoclonal antibody, dubbed RGI6004.

A multiplex sandwich assay utilizing fluorescent antibody-conjugated beads was used to quantify ... active IBD patients compared to inactive patients. In contrast, measured IL-10 levels were lower in ...

The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. The company was spun ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been published in the journal Molecular Biomedicine. The review provides ...

A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.